Many factors can contribute to EndMT, including loss of function of bone morphogenetic protein receptor-2 (BMPR2), a gene that is mutated in most patients with familial PAH and in 20% of those without a family history of PAH (6). The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.